ARCHIVES

Also FDA clarifies data requirements for phase I IND applications.

This article is from The Cancer Letter archive.

Vol. 31 No. 17 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

Last Issue Until Aug. 20

July 30, 1982

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

March 3, 2006

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

Congressman Requests GAO Inquiry into FDA Foreign Inspections

April 19, 1996